The FDA sent out an update on November 10 regarding drugs that are currently in shortage:
- Dextrose Injection USP, 70% (Updated – Currently in Shortage)
- Lindane Lotion, USP 1% (New – Discontinuation)
- Lindane Shampoo, USP 1% (New – Discontinuation)
- Multi-Vitamin Infusion (Adult and Pediatric) (Updated – Currently in Shortage)
- Penicillin G Benzathine (Bicillin L-A) Injection (Updated – Currently in Shortage)
- Penicillin G Benzathine and Penicillin G Procaine (Bicillin C-R) Injection (Updated – Currently in Shortage)
- Penicillin G Procaine Injection (Updated – Currently in Shortage)
- Potassium Chloride Injection (Updated – Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
